Overall market sentiment has been high on Johnson & Johnson (JNJ) stock lately. JNJ receives a Bullish rating from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company.
Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.
InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.
The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.
What's Happening With JNJ Stock Today?
Johnson & Johnson (JNJ) stock has risen 1.19% while the S&P 500 is down -0.96% as of 2:46 PM on Tuesday, May 4. JNJ has gained $1.97 from the previous closing price of $165.21 on volume of 5,562,502 shares. Over the past year the S&P 500 is up 46.07% while JNJ has gained 12.75%. JNJ earned $5.66 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 29.52.
To see the top 5 stocks in the Drug Manufacturers - General industry click here.
More About Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total revenue is generated in the United States.
Click Here to get the full Stock Score Report on Johnson & Johnson (JNJ) Stock.
